clopidogrel and Adverse Drug Event

clopidogrel has been researched along with Adverse Drug Event in 41 studies

Research

Studies (41)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (12.20)	29.6817
2010's	30 (73.17)	24.3611
2020's	6 (14.63)	2.80

Authors

Authors	Studies
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W	1
Kalgutkar, AS	1
Bennett, CL; Godwin, AC; Hoque, S; Taylor, MA	1
Denda, M; Goda, M; Hamano, H; Higashionna, T; Ishizawa, K; Lin, TJ; Miyata, K; Nawa, H; Neishi, M; Niimura, T; Yagi, K; Zamami, Y	1
Fukuta, H; Hagiwara, H; Ishizawa, K; Kamiya, T; Kimura, K; Niimura, T; Ohte, N; Zamami, Y	1
Chen, Q; Li, D; Lu, C; Wang, C; Wang, S; Wang, Y; Wang, Z; Xu, T; Xuan, H; Zhang, H; Zhang, Y	1
Aoki, Y; Chandler, RE; Lönnstedt, IM; Wakao, R	1
Bhatt, DL; Day, JRS; Gibson, CM; Hamm, CW; Mahaffey, KW; Parker, WA; Prats, J; Price, MJ; Steg, PG; Stone, GW; Storey, RF; White, HD	1
Godier, A; Houssany-Pissot, S; Martin, AC; Taylor, G; Zlotnik, D	1
Asri, S; Cham, YL; Chin, FYY; Fong, AYY; Gerunsin, J; Khiew, NZ; Koh, KT; Kong, KL; Lim, MSH; Mejin, M; Mohd Amin, NH; Ong, TK; Oon, YY; Tan, SSN; Tiong, LL; Voon, CY	1
An, JH; Kim, EJ; Kim, SG; Lee, DW; Lee, JH; Lee, SG; Shim, KS	1
Li, W; Li, X; Lu, Y; Sun, S; Yang, M; Zhao, K; Zhao, Z	1
Huang, J; Liu, L; Tang, X; Zhang, X	1
Cavallari, LH; El Wakeel, LL; Fathy, S; Khalil, BM; Langaee, T; Sabry, NA; Saleh, A; Schaalan, MF; Shahin, MH	1
Agewall, S; Atar, D; Geudelin, B; Hall, TS; Hyun Kim, M; Lomakin, N; Marciniak, TA; Serebruany, VL	1
Aradi, D; Bonello, L; Burtey, S; Dabry, T; Frere, C; Laine, M; Lemesle, G; Mancini, J; Paganelli, F; Puymirat, E; Sibbing, D; Thuny, F	1
Baccar, H; Boughalleb, M; Charfi, R; Gorgi, Y; Hammami, N; Hosni, H; Kharrat, M; Klouz, A; Kouidhi, S; Limam, M; Mrabet, A; Mzoughi, K; Sfar, I; Trabelsi, S; Zaïri, I; Zedini, C	1
Danahey, K; Knoebel, RW; Lee, YM; Meltzer, DO; O'Donnell, PH; Ratain, MJ	1
Albers, GW; Barsan, WG; Cucchiara, BL; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Kleindorfer, DO; Lindblad, AS; Lutsep, HL; Palesch, YY; Pearson, C; Sethi, P; Vora, N; Zurita, KG	1
Blais, DM; Firstenberg, MS; Hayes, C; Pickworth, KK; Porter, K; Zukkoor, SM	1
Holm, L; Loikas, D; Malmström, RE; Mejyr, S; Rydberg, DM; Schenck-Gustafsson, K; von Euler, M; Wettermark, B	1
Slørdal, L; Spigset, O; Staurset, HB; Søraas, IA	1
Aslani, P; Blalock, SJ; Raynor, DK; Tong, V	1
Devine, B; Nishimura, AA; Salama, J; Shirts, BH; Smith, JW; Tarczy-Hornoch, P	1
Bae, SK; Kim, GJ; Kim, JH; Lee, J; Lee, S; Lim, HS; Noh, Y; Oh, E; Shin, S	1
Brandt, JT; Farid, NA; Jakubowski, JA; Li, YG; Payne, CD; Salazar, DE; Small, DS; Winters, KJ	1
Bauer, T; Gitt, AK; Heer, T; Juenger, C; Senges, J; Towae, F; Zahn, R; Zeymer, U	1
Capodanno, D; Capranzano, P; Di Salvo, ME; Francaviglia, B; Galassi, AR; Mirabella, F; Tamburino, C; Ussia, GP	1
Ahmed, N; Diedler, J; Ford, GA; Lees, KR; Luijckx, GJ; Overgaard, K; Ringleb, P; Soinne, L; Sykora, M; Uyttenboogaart, M; Wahlgren, N	1
Hadad, E; Kramer, E; Shalom, A; Westreich, M	1
Bai, JP	1
Hassan, AE; Qureshi, AI; Rodriguez, GJ; Suri, MF; Taylor, RA; Tummala, RP; Vazquez, G; Zacharatos, H	1
Donohue, MM; Tirschwell, DL	1
Kleiman, NS; Mangalpally, KK	1
Kukes, IV; Paukov, SV; Ruvinov, IuV; Sivkov, AS	1
Giraldo-Giraldo, C; Machado-Alba, JE; Moncada-Escobar, JC	1
Gammack, JK; Messinger-Rapport, BJ; Morley, JE; Thomas, DR	1
Dolgin, E	1
Acheré, C; Boulé, S; Brigadeau, F; Goéminne-Boulé, C; Guédon-Moreau, L; Kacet, S; Klug, D; Kouakam, C; Lacroix, D; Marquié, C; Vanesson-Bricout, C	1
Rivkin, A	1
Byrne, S; Gallagher, P; Kennedy, J; O'Mahony, D; Ryan, C	1

Reviews

8 review(s) available for clopidogrel and Adverse Drug Event

Article	Year
Efficacy and safety of low dose ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis. Postgraduate medical journal, 2020, Volume: 96, Issue:1141 Topics: Acute Coronary Syndrome; Clopidogrel; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Humans; Off-Label Use; Platelet Aggregation Inhibitors; Ticagrelor; Treatment Outcome	2020
[Management of the bleeding risk associated with antiplatelet agents]. La Revue de medecine interne, 2017, Volume: 38, Issue:7 Topics: Adenosine; Aspirin; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor; Ticlopidine	2017
P2Y12 Polymorphisms and the Risk of Adverse Clinical Events in Patients Treated with Clopidogrel: A Meta-Analysis. Drug research, 2019, Volume: 69, Issue:1 Topics: Case-Control Studies; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Genotype; Humans; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Receptors, Purinergic P2Y12; Risk	2019
Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis. PloS one, 2018, Volume: 13, Issue:6 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stents; Stroke; Thrombosis; Warfarin	2018
Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease. Thrombosis and haemostasis, 2018, Volume: 118, Issue:10 Topics: Acute Coronary Syndrome; Administration, Oral; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; France; Hemorrhage; Humans; Odds Ratio; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Survival Analysis; Ticagrelor; Treatment Outcome	2018
Ongoing challenges in drug interaction safety: from exposure to pharmacogenomics. Drug metabolism and pharmacokinetics, 2010, Volume: 25, Issue:1 Topics: Administration, Oral; Camptothecin; Clopidogrel; Drug Evaluation; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inactivation, Metabolic; Injections, Intravenous; Irinotecan; Maximum Tolerated Dose; Membrane Transport Proteins; Models, Biological; Models, Statistical; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic; Ticlopidine	2010
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel. Current neurology and neuroscience reports, 2011, Volume: 11, Issue:1 Topics: Anticoagulants; Clopidogrel; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Genome-Wide Association Study; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome; Warfarin	2011
The safety of clopidogrel. Expert opinion on drug safety, 2011, Volume: 10, Issue:1 Topics: Acute Coronary Syndrome; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Ticlopidine	2011

Trials

3 trial(s) available for clopidogrel and Adverse Drug Event

Article	Year
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study. Thrombosis and haemostasis, 2017, 06-02, Volume: 117, Issue:6 Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Occlusion; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Percutaneous Coronary Intervention; Receptors, Purinergic P2Y12; Survival Analysis; Ticlopidine; Treatment Outcome; Withholding Treatment	2017
Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke. Circulation, 2019, 08-20, Volume: 140, Issue:8 Topics: Acute Disease; Aspirin; Clinical Protocols; Clopidogrel; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Hemorrhage; Humans; Ischemia; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Risk Assessment; Stroke; Time Factors	2019
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects. Platelets, 2008, Volume: 19, Issue:4 Topics: Adenosine Diphosphate; Adult; Aspirin; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Female; Hemorrhage; Humans; Male; Middle Aged; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Thiophenes; Ticlopidine	2008

Other Studies

30 other study(ies) available for clopidogrel and Adverse Drug Event

Article	Year
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology, 2011, Volume: 7, Issue:12 Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests	2011
Designing around Structural Alerts in Drug Discovery. Journal of medicinal chemistry, 2020, 06-25, Volume: 63, Issue:12 Topics: Drug Design; Drug Development; Drug Discovery; Drug-Related Side Effects and Adverse Reactions; Humans; Molecular Structure; Pharmaceutical Preparations; Structure-Activity Relationship	2020
Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions. Cancer treatment and research, 2022, Volume: 184 Topics: Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Humans; Immunotherapy; Thalidomide; Ticlopidine; United States	2022
Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databases. Toxicology and applied pharmacology, 2023, 09-15, Volume: 475 Topics: Adverse Drug Reaction Reporting Systems; Cilostazol; Clopidogrel; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Esomeprazole; Hemorrhage; Humans; Omeprazole; Prasugrel Hydrochloride; United States	2023
Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting Databases. International journal of medical sciences, 2020, Volume: 17, Issue:6 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clinical Trials, Phase III as Topic; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists	2020
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan. Drug safety, 2021, Volume: 44, Issue:6 Topics: Adverse Drug Reaction Reporting Systems; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Humans; Irinotecan; Japan; Voriconazole	2021
Association of CYP2C192 polymorphism with clopidogrel response and 1-year major adverse cardiovascular events in a multiethnic population with drug-eluting stents. Pharmacogenomics, 2017, Volume: 18, Issue:13* Topics: Alleles; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Factors; Ticlopidine	2017
Intramuscular hematoma with motor weakness after trigger point injection: A case report. Medicine, 2017, Volume: 96, Issue:39 Topics: Aged; Biopsy, Fine-Needle; Buttocks; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Female; Glucocorticoids; Hematoma; Humans; Image-Guided Biopsy; Injections, Epidural; Low Back Pain; Muscle Weakness; Muscle, Skeletal; Platelet Aggregation Inhibitors; Spinal Stenosis; Ticlopidine; Treatment Outcome; Trigger Points; Ultrasonography	2017
Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians. Pharmacogenetics and genomics, 2018, Volume: 28, Issue:9 Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Egypt; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pharmacogenetics; Platelet Aggregation Inhibitors; Risk Factors; Stroke	2018
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System. European heart journal. Cardiovascular pharmacotherapy, 2019, 10-01, Volume: 5, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Aged; Cause of Death; Clopidogrel; Data Mining; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Drugs, Generic; Female; Humans; Male; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Registries; Risk Assessment; Risk Factors; United States; United States Food and Drug Administration	2019
Response to clopidogrel and of the cytochrome CYP2C19 gene polymorphism. La Tunisie medicale, 2018, Volume: 96, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Drug-Related Side Effects and Adverse Reactions; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Genotyping Techniques; Hemorrhage; Heterozygote; Humans; Longitudinal Studies; Male; Middle Aged; Pharmacogenomic Testing; Polymorphism, Genetic; Tunisia	2018
Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing. Pharmacogenetics and genomics, 2019, Volume: 29, Issue:2 Topics: Aged; Aged, 80 and over; Clopidogrel; Codeine; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Pharmacogenetics; Pharmacogenomic Variants; Prescription Drugs; Warfarin	2019
Bleeding outcomes associated with coronary artery bypass graft surgery and recent clopidogrel exposure. The heart surgery forum, 2013, Volume: 16, Issue:2 Topics: Causality; Clopidogrel; Comorbidity; Coronary Artery Bypass; Drug-Related Side Effects and Adverse Reactions; Female; Hospital Mortality; Humans; Male; Middle Aged; Ohio; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prevalence; Retrospective Studies; Risk Assessment; Survival Analysis; Survival Rate; Ticlopidine; Treatment Outcome	2013
Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment. European journal of clinical pharmacology, 2014, Volume: 70, Issue:1 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aspirin; Child; Child, Preschool; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Middle Aged; Practice Patterns, Physicians'; Risk; Sex Factors; Sweden; Ticlopidine; Warfarin; Young Adult	2014
[Drug-drug interactions in nursing home patients]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2014, May-27, Volume: 134, Issue:10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Clopidogrel; Databases, Factual; Dopamine Antagonists; Drug Interactions; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Humans; Nursing Homes; Platelet Aggregation Inhibitors; Polypharmacy; Proton Pump Inhibitors; Ticlopidine; Warfarin	2014
Exploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leaflets. Health expectations : an international journal of public participation in health care and health policy, 2016, Volume: 19, Issue:3 Topics: Aged; Antihypertensive Agents; Attitude; Clopidogrel; Cognition; Drug-Related Side Effects and Adverse Reactions; Female; Focus Groups; Health Literacy; Heuristics; Humans; Male; Middle Aged; New South Wales; Pamphlets; Platelet Aggregation Inhibitors; Prescription Drugs; Ramipril; Terminology as Topic; Ticlopidine	2016
Physician perspectives of CYP2C19 and clopidogrel drug-gene interaction active clinical decision support alerts. International journal of medical informatics, 2016, Volume: 86 Topics: Adult; Adverse Drug Reaction Reporting Systems; Clopidogrel; Cytochrome P-450 CYP2C19; Decision Support Systems, Clinical; Drug Interactions; Drug Therapy, Computer-Assisted; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Medical Order Entry Systems; Medication Errors; Middle Aged; Pharmacogenetics; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Reminder Systems; Ticlopidine; User-Computer Interface; Young Adult	2016
Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database. PloS one, 2016, Volume: 11, Issue:3 Topics: Aspirin; Cilostazol; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Hemorrhage; Humans; Insurance, Health; Korea; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Succinates; Tetrazoles; Ticlopidine; Treatment Outcome	2016
Efficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practice. Journal of thrombosis and thrombolysis, 2009, Volume: 28, Issue:3 Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Drug Evaluation; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Hospital Mortality; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Ticlopidine; Treatment Outcome	2009
Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results. The Journal of invasive cardiology, 2009, Volume: 21, Issue:4 Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Databases as Topic; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Time Factors; Treatment Outcome	2009
Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke, 2010, Volume: 41, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Contraindications; Dipyridamole; Drug Incompatibility; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Ticlopidine; Tissue Plasminogen Activator; Treatment Outcome; Young Adult	2010
Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls. The American surgeon, 2010, Volume: 76, Issue:1 Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Dermatologic Surgical Procedures; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythema; Female; Follow-Up Studies; Hematoma; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Surgical Wound Dehiscence; Surgical Wound Infection; Ticlopidine; Warfarin	2010
Low risk of intracranial and systemic hemorrhages in patients on dual antiplatelet treatment beyond 1 month following neuroendovascular angioplasty and/or stent placement. Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2012, Volume: 22, Issue:1 Topics: Angioplasty; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Minnesota; Platelet Aggregation Inhibitors; Prevalence; Radiography; Risk Assessment; Risk Factors; Stents; Survival Analysis; Survival Rate; Ticlopidine; Treatment Outcome	2012
[Individual pharmacotherapy safety in the assessment of cytochrome P-450 3A4 (CYP3A4) isoenzyme activity]. Klinicheskaia meditsina, 2010, Volume: 88, Issue:2 Topics: Atorvastatin; Clinical Trials as Topic; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Enzyme Induction; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Ischemia; Pharmacokinetics; Platelet Aggregation Inhibitors; Precision Medicine; Pyrroles; Ticlopidine	2010
[Active pharmacosurveillance of patients affiliated to the Colombian general social security/health system]. Revista de salud publica (Bogota, Colombia), 2010, Volume: 12, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Calcium Channel Blockers; Clopidogrel; Colombia; Diphosphonates; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Imidazoles; Losartan; Medication Systems; Metoprolol; National Health Programs; Omeprazole; Retrospective Studies; Social Security; Software; Ticlopidine; Zoledronic Acid	2010
Clinical update on nursing home medicine: 2011. Journal of the American Medical Directors Association, 2011, Volume: 12, Issue:9 Topics: Anti-Ulcer Agents; Anticoagulants; Atrial Fibrillation; Clopidogrel; Clostridioides difficile; Delirium; Diabetes Complications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Fractures, Bone; Geriatric Nursing; Humans; Male; Nursing Homes; Omeprazole; Osteoporosis; Peptic Ulcer; Platelet Aggregation Inhibitors; Pneumonia, Bacterial; Polypharmacy; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Warfarin; Weight Loss	2011
Preemptive genotyping trialed to prevent adverse drug reactions. Nature medicine, 2011, Nov-07, Volume: 17, Issue:11 Topics: Clinical Trials as Topic; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Genetic Testing; Genotype; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Ticlopidine	2011
Clopidogrel increases bleeding complications in patients undergoing heart rhythm device procedures. Pacing and clinical electrophysiology : PACE, 2012, Volume: 35, Issue:5 Topics: Cardiac Resynchronization Therapy; Case-Control Studies; Clopidogrel; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; France; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Ticlopidine; Treatment Outcome	2012
Admissions to a medical intensive care unit related to adverse drug reactions. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Sep-01, Volume: 64, Issue:17 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Female; Hemorrhage; Hospitalization; Hospitals, Teaching; Humans; Intensive Care Units; Male; Platelet Aggregation Inhibitors; Ticlopidine	2007
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. International journal of clinical pharmacology and therapeutics, 2008, Volume: 46, Issue:2 Topics: Abbreviations as Topic; Age Factors; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bendroflumethiazide; Clopidogrel; Delphi Technique; Digoxin; Diuretics; Drug Prescriptions; Drug Therapy; Drug Utilization Review; Drug-Related Side Effects and Adverse Reactions; Glomerular Filtration Rate; Health Services for the Aged; Humans; Ireland; Metformin; Practice Patterns, Physicians'; Reproducibility of Results; Risk Factors; Ticlopidine; Time Factors; United Kingdom	2008